Tag: Prostate cancer

What if the promise of a treatment turned out to be a setback? Insulin potentiation therapy, once seen by some as a gentler cancer solution, may actually shorten survival for men with hormone resistant metastatic prostate cancer—a stark reminder that not all hopeful new therapies deliver on their claims. keep reading

Can a cancer diagnosis bring a sense of relief? For men with prostate cancer caught at Grade Group 1, emerging research and expert protocols suggest that aggressive treatments can often be avoided. Active surveillance, targeted focal therapies, and more precise diagnostic tools are helping many choose paths that spare quality of life. keep reading

The FDA has approved ArteraAI Prostate, an innovative AI tool trained on thousands of biopsy images and clinical data, to help assess the risk of prostate cancer progression and personalize treatment plans. Doctors and patients can now benefit from faster, more accurate risk predictions. keep reading

What if aging wasn’t the real reason behind fading sex drive? Emerging research points to metabolic health as the underappreciated culprit, suggesting that healthy habits around diet and exercise could offer more influence over vitality in the bedroom than age itself. keep reading

What if treating prostate cancer didn’t have to mean sacrificing the whole gland? Thanks to advances in multiparametric MRI and MRI-targeted biopsy, focal therapy can pinpoint and erase tumors with a margin of safety while sparing healthy tissue. Lower side effect rates and preserved function set this approach apart. keep reading

For decades, the prostate was thought to be a sterile organ, but recent discoveries reveal a unique microbial community at play. Certain bacteria found in prostate tissue may spark inflammation, influence cancer risk, and even shape treatment strategy, suggesting that diet and gut health are more connected to prostate cancer than many realize. keep reading

Research indicates that regular mpMRI scans and PSA density checks might allow some prostate cancer patients on active surveillance to delay confirmatory biopsy at one year. While the evidence is promising, experts say more study is needed before changing established protocols. keep reading

Choosing the right prostate cancer treatment goes beyond medical statistics—it's about aligning therapy with individual lifestyles, priorities, and long-term well-being. Shared decision-making, patient-reported outcomes, and emerging therapies offer hope for better cancer control with fewer side effects. keep reading

Discover how PI-RADS v2.1 has raised the bar for prostate cancer detection, and how the new PI-RR system helps identify recurrence after surgery or radiation. Updated imaging guidelines are making diagnosis and follow-up more reliable. keep reading

Recent long-term data reveal that active surveillance can offer high prostate cancer-specific survival when paired with advanced monitoring tools like multiparametric MRI and biomarkers. Experts emphasize the importance of a proactive, technology-driven approach to achieve the best treatment-free survival. keep reading